-HCC-GRIm-Score- a new tool integrated AST-to-ALT ratio and TBIL to GRIm-Score based on three objective variables, namely, NLR, serum albumin level, and LDH may have higher predictive value in identifying HCC patients who would benefit from ICIs therapy. This evidence concerns the gene GPT and hepatocellular carcinoma.